DexCom is trading 6.16% higher at $88.08 on November 4, 2026, with broad market strength the likeliest context for the gain. - The S&P 500 is up 1.62%, Nasdaq 2.11%, and Dow 2.22%. - No clear company-specific announcement explaining the intraday move surfaced in available search results. - Recent coverage highlighted the Canadian G7 15 Day launch and Q3 results, but does not establish either as the cause of this morning’s move.